Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...

From the sweet aroma of baked cookies to the festive family gatherings, Shawn Hundertmark’s mom always put the merry in Christmas. When she died 20 years ago, Hundertmark dedicated his yearly ...

The holidays are a popular time for giving. Some enjoy passing out presents while others choose to volunteer, but this year, a social media trend encourages people to do a mix of both. People are ...

Allie Greene discovered her local Walmart Angel Tree overflowing with unclaimed tags — so she turned to TikTok for help Allie Greene Allie Greene discovered her local Walmart Angel Tree overflowing ...

Decorated by the Skunk Train and towering over 200 feet, the living tree in Fort Bragg and Willits tops a new global ranking. Kristine Hansen is a design, food and drink, and travel writer based in ...

This year's tree is a 75-foot Norway spruce from East Greenbush, New York. The Rockefeller Center tree is lit and the holiday season is underway in New York City. Host Reba McEntire, Marc Anthony, ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

A tree trimmer fell to his death while on the job in Canoga Park on Monday, according to the Los Angeles Fire Department. The tragedy was reported just before 3:30 p.m. along Canoga Avenue and Valerio ...

The Rockefeller Center Christmas tree was hoisted aloft at its new home in Manhattan on Saturday, marking the start of New York City’s holiday season. This year’s tree is a 75-foot-tall Norway spruce ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...